1. Glycan profile of CHO derived IgM purified by highly efficient single step affinity chromatography
   Julia Hennicke et al, 2017, Analytical Biochemistry CrossRef
2. Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance
   Nely Rodriguez-Zhurbenko et al, 2015, Ann. N.Y. Acad. Sci. CrossRef
3. Beyond the Role of CD55 as a Complement Component
   So Hee Dho et al, 2018, Immune Netw CrossRef
4. Complement system's role in cancer and its therapeutic potential in ovarian cancer
   H. Bareke et al, 2018, Scand J Immunol CrossRef
5. Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer
   So Hee Dho et al, 2018, Sci Rep CrossRef
6. Impact of temperature and pH on recombinant human IgM quality attributes and productivity
   Julia Hennicke et al, 2019, New Biotechnology CrossRef
7. CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma
   F Cimmino et al, 2016, Oncogenesis CrossRef
8. Considerations for the Design of Antibody-Based Therapeutics
   Dennis R. Goulet et al, 2019, Journal of Pharmaceutical Sciences CrossRef
9. PAT SC1
   , 2015, Reactions Weekly CrossRef
10. Site-Specific N-Glycosylation of Recombinant Pentameric and Hexameric Human IgM
    Edward S. X. Moh et al, 2016, J. Am. Soc. Mass Spectrom. CrossRef
11. Structure, Function, and Therapeutic Use of IgM Antibodies
    Bruce A. Keyt et al, 2020, Antibodies CrossRef
12. Glycoarrays for diagnosis and therapy of the disorders of the female reproductive system
    N. V. Shilova et al, 2021, Russian Journal of Immunology CrossRef
13. The active form of Helicobacter pylori vacuolating cytotoxin induces decay‐accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa
    Kazuyo Kaneko et al, 2022, The Journal of Pathology CrossRef
14. CD55 in cancer: Complementing functions in a non-canonical manner
    Rashmi Bharti et al, 2022, Cancer Letters CrossRef
15. A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma
    Davide Busato et al, 2023, J Transl Med CrossRef
16. The role of B-1 cells in cancer progression and anti-tumor immunity
    Nely Rodríguez-Zhurbenko et al, 2024, Front. Immunol. CrossRef
17. Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
    Maya R. MacLean et al, 2024, IJMS CrossRef
18. Complement regulators as novel targets for anti-cancer therapy: A comprehensive review
    Ruchi Saxena et al, 2025, Seminars in Immunology CrossRef